Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A DORIA

Showing results (331-340 of 667) with videos related to

Pageof 67
Sort By:
Iscience|February 6, 2024
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer baseHongying Duan, Angela R Corrigan, Cheng Cheng, et al.
Nature Communications|June 22, 2023
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infectionsWanwisa Promsote, Ling Xu, Jason Hataye, et al.
Immunity|May 18, 2017
Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding LoopEvan M Cale, Jason Gorman, Nathan A Radakovich, et al.
Cell Reports|February 15, 2018
Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing AntibodyYoung D Kwon, Gwo-Yu Chuang, Baoshan Zhang, et al.
Science (New York, N.Y.)|August 13, 2011
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencingXueling Wu, Tongqing Zhou, Jiang Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 5, 2024
Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1Jianliang Xu, Tongqing Zhou, Krisha McKee, et al.
Immunity|November 17, 2016
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization BreadthJinghe Huang, Byong H Kang, Elise Ishida, et al.
The New England Journal of Medicine|December 3, 2020
Durability of Responses after SARS-CoV-2 mRNA-1273 VaccinationAlicia T Widge, Nadine G Rouphael, Lisa A Jackson, et al.
Nature Communications|August 28, 2024
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIV<sub>AD8-EO</sub> infectionJoana Dias, Giulia Fabozzi, Slim Fourati, et al.
Journal of Virology|October 16, 2015
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional PotencyNicole A Doria-Rose, Jinal N Bhiman, Ryan S Roark, et al.
Pageof 67

Showing results (331-340 of 667) with videos related to

Sort By:
Pageof 67
Iscience|February 6, 2024
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer baseHongying Duan, Angela R Corrigan, Cheng Cheng, et al.
Nature Communications|June 22, 2023
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infectionsWanwisa Promsote, Ling Xu, Jason Hataye, et al.
Immunity|May 18, 2017
Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding LoopEvan M Cale, Jason Gorman, Nathan A Radakovich, et al.
Cell Reports|February 15, 2018
Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing AntibodyYoung D Kwon, Gwo-Yu Chuang, Baoshan Zhang, et al.
Science (New York, N.Y.)|August 13, 2011
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencingXueling Wu, Tongqing Zhou, Jiang Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 5, 2024
Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1Jianliang Xu, Tongqing Zhou, Krisha McKee, et al.
Immunity|November 17, 2016
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization BreadthJinghe Huang, Byong H Kang, Elise Ishida, et al.
The New England Journal of Medicine|December 3, 2020
Durability of Responses after SARS-CoV-2 mRNA-1273 VaccinationAlicia T Widge, Nadine G Rouphael, Lisa A Jackson, et al.
Nature Communications|August 28, 2024
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIV<sub>AD8-EO</sub> infectionJoana Dias, Giulia Fabozzi, Slim Fourati, et al.
Journal of Virology|October 16, 2015
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional PotencyNicole A Doria-Rose, Jinal N Bhiman, Ryan S Roark, et al.
Pageof 67